ArticleDrug design, development and therapy2021

Roflumilast Attenuates Doxorubicin-Induced Cardiotoxicity by Targeting Inflammation and Cellular Senescence in Cardiomyocytes Mediated by SIRT1.

Sheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.